NEW PHARMACEUTICAL PLANT OPENED IN KYIV OBLAST
New pharmaceutical plant, Biofarma, opened in Bila Tserkva (Kyiv Oblast).
Biofarma enters TOP-10 Ukrainian biggest medicines manufactures, it produces more than 20 immunobiological medicines from donated blood and medicines made from recombinant DNA and probiotics. Blood products make about 80% of total company’s export, when export makes about 50% of total company’s production volume.
The new enterprise provides about 300 jobs. The sum of investments consists about $40 million.
100% company’s interest belong to Niobera Investments Limited (Cyprus). In 2012 the company’s shares were purchased by Holland Development Bank FMO and Investment Fund Emerging Europe Growth Fund II (EEGF II) headed by Horizon Capital.